Caplin Point Laboratories Limited (BOM:524742)

India · Delayed Price · Currency is INR

1,644.60

-5.80 (-0.35%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Formulations	19.40B	16.96B	14.68B	12.71B	10.62B
Pharmaceutical Formulations Growth	14.35%	15.51%	15.53%	19.64%	22.96%
Total	19.40B	16.96B	14.68B	12.71B	10.62B
Total Growth	14.35%	15.51%	15.53%	19.64%	22.96%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Rest of The World	15.83B	13.81B	-	-	-
Rest of The World Growth	14.65%	-	-	-	-
United States of America (USA)	3.55B	3.13B	-	1.27B	-
United States of America (USA) Growth	13.13%	-	-	-	-
Unallocated	964.30M	669.40M	-	-	-
Unallocated Growth	44.05%	-	-	-	-
Latin America	-	-	-	11.04B	-
Africa	-	-	-	380.82M	-
Total	20.34B	17.61B	-	12.69B	-
Total Growth	15.49%	-	-	-	-

Source: S&P Global Market Intelligence.